APA (7th ed.) Citation

NS, G., AM, A., CL, H., GM, G., R, d. l. R. R., JL, B., & DN, A. (2020). Fenofibrate Improves Liver Function and Reduces the Toxicity of the Bile Acid Pool in Patients With Primary Biliary Cholangitis and Primary Sclerosing Cholangitis Who Are Partial Responders to Ursodiol. Clinical pharmacology and therapeutics, 108(6), 1213. https://doi.org/10.1002/cpt.1930

Chicago Style (17th ed.) Citation

NS, Ghonem, Auclair AM, Hemme CL, Gallucci GM, de la Rosa Rodriguez R, Boyer JL, and Assis DN. "Fenofibrate Improves Liver Function and Reduces the Toxicity of the Bile Acid Pool in Patients With Primary Biliary Cholangitis and Primary Sclerosing Cholangitis Who Are Partial Responders to Ursodiol." Clinical Pharmacology and Therapeutics 108, no. 6 (2020): 1213. https://doi.org/10.1002/cpt.1930.

MLA (9th ed.) Citation

NS, Ghonem, et al. "Fenofibrate Improves Liver Function and Reduces the Toxicity of the Bile Acid Pool in Patients With Primary Biliary Cholangitis and Primary Sclerosing Cholangitis Who Are Partial Responders to Ursodiol." Clinical Pharmacology and Therapeutics, vol. 108, no. 6, 2020, p. 1213, https://doi.org/10.1002/cpt.1930.